Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Energy Blue is a biotechnology company focused on the conversion of agricultural waste into high-value, low-carbon fuels and chemicals. The company utilizes its proprietary Inbicon bioconversion technology to refine biomass, such as corn stover and wheat straw, into cellulosic ethanol and clean lignin. Its business model involves designing, building, and operating biomass refineries, with its flagship facility, New Energy Freedom, located in Mason City, Iowa. Through its subsidiary New Energy Chemicals, the company also produces bio-based ethylene for use in sustainable plastics and aviation fuel. New Energy Blue aims to decarbonize the transportation and chemical industries by providing scalable, plant-based alternatives to fossil fuels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Energy.